Kruger Nutra Med Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 14.23%
- Profit Growth 352.25%
- Ebitda 79.44%
- Net Worth 2.76%
- Total Assets 65.75%
About Kruger Nutra Med
Kruger Nutra Med Private Limited (KNMPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2005 and has a history of 19 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Kapoor, Aditya Kapur, and Nitin Kapur serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2005PTC140005
-
Company No.
140005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Kruger Nutra Med Private Limited offer?
Kruger Nutra Med Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs.
Who are the key members and board of directors at Kruger Nutra Med?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Kapoor
|
Director | 25-Aug-2005 | Current |
|
Aditya Kapur
|
Director | 16-Mar-2012 | Current |
|
Nitin Kapur
|
Director | 16-Mar-2012 | Current |
Financial Performance of Kruger Nutra Med.
Kruger Nutra Med Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.23% increase. The company also saw a substantial improvement in profitability, with a 352.25% increase in profit. The company's net worth moved up by a moderate rise of 2.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kruger Nutra Med?
In 2020, Kruger Nutra Med had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kruger Nutra Med?
Unlock and access historical data on people associated with Kruger Nutra Med, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kruger Nutra Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kruger Nutra Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
